Ahmed Lab @ Northwestern

Check out our lab’s new #YouTube channel! We have spent the #COVID19 #Quarantine building #educational material about common #research practices and skills. 👩🏻‍🔬🔬 See videos and subscribe: bit.ly/ahmed-lab Material by @ShivaniBaisi #science #education #virtual

@JustinLathia Congrats Justin!

Thanks so much, Mike! Thrilled to have this opportunity to continue to build neuro oncology research here at the Cleveland Clinic!

#SNO2025 @NeurosurgeryNM @BrainTumorInst

Kicked off our stay in Hawaii for #SNO2025 with a hike to Awaawaloa (Mt Olympus). The narrow trail was challenging but the view from the top was worth it! @NeurosurgeryNM @BrainTumorInst #NeuroOncology

@DanWahlMD @Nature @AndrewScottPhD Congrats Dan! Beautiful work.

New discovery from our team defining how human brain cancers rewire the metabolism of the normal brain published today @Nature and led by @AndrewScottPhD nature.com/articles/s4158…

I had the opportunity to attend the postdoc lunch with Dr Antonio Omuro of @StanfordMed today, followed by his talk at @BrainTumorInst Seminar series. Don’t have pictures from the lunch, but I left feeling motivated - in these troubling times, we must keep working hard!

#ICYMI MBTI's very own Priya Kumthekar, MD, Atique Ahmed, PhD, and Ditte Primdahl, MD, will be attending the 6th annual Glioblastoma Drug Development Summit. Dr. Kumthekar will host a roundtable, while Professor Ahmed and Dr. Primdahl will host workshops. ter.li/uaqytp

I wish I heard this George Church (@geochurch) podcast episode when I was a grad student! 1. You can change the world, as long as you don't care who gets credit. 2. The idea is not to never fail, it is to fail a million times a day. 3. Embrace the outlier!

Happy holidays! @BrainTumorInst @NeurosurgeryNM

⁦@atiqueahmedphd⁩ discussing clinical trial data & therapeutic resistance ⁦in #GBM ⁦@NUFeinbergMed⁩ ⁦@BrainTumorInst⁩. #BIBC Symposium ⁦@umichmedicine⁩ ⁦@umichneuro⁩⁩ ⁦@UMRogelCancer⁩ ⁦@UMneurosciences⁩ ⁦@umpharmacy⁩ ⁦

We are pleased to host the first Day of Celebration for brain tumor patients, caregivers, loved ones, advocates, and ambassadors. Join us for a family-friendly social event! Click the link for more info: ow.ly/S0xj50TVx9z

Please join us for a day of celebration on Sunday, November 10, for brain tumor patients, their families, caregivers, advocates, and ambassadors. Enjoy music, games, food and connecting with other members of the brain tumor community. cancer.northwestern.edu/events/public/…

@NeurosurgeryNM @BrainTumorInst Great participation at annual meeting with our medical students. 18 posters 6 oral presentations 2 awards The next generation of future neurosurgeons is coming on strong!

Northwestern continues to distinguish itself as a top research university, ranking #6 in @usnews 2024 national survey of best colleges. usnews.com/best-colleges/… #northwestern #ranking #research #excellence #education

#Glioblastoma is a highly aggressive and malignant #BrainTumor with limited therapeutic options and a poor prognosis. A promising alternative strategy is to harness the immune system's potential against tumor cells. Previous data showed that the B-cell-based vaccine can induce therapeutic responses in preclinical models of glioblastoma. This study, co-authored by @NorthwesternMed neurologists, aimed to characterize the antigenic reactivity of the vaccine’s antibodies and evaluate their therapeutic potential. Learn more: pubmed.ncbi.nlm.nih.gov/39207859 #MedTwitter #NeuroTwitter

Thank you @BrainUp.ngo for your incredible dedication to raising awareness and supporting brain cancer research. Together, we’re making strides toward a cure! 🙌 @BrainTumorInst @NeurosurgeryNM @HeimbergerAmy @atiqueahmedphd #BrainCancerAwareness #ResearchMatters #BrainUp

@Eunus_Sheemul Good luck Eunus!

Today is #GlioblastomaAwarenessDay, a time to raise awareness about #glioblastoma (GBM), the most common, complex, & difficult to treat type of #BrainCancer. Hear from MBTI #BrainTumor patients, including those living with a #GBM diagnosis: youtu.be/9Q-hg8r8I9g?si…. @LurieCancer

MBTI's Priya Kumthekar, MD recently led a national study of advanced #CSF analyses of patients with HER2+ #BreastCancer & leptomeningeal #metastases. Learn about this retrospective analysis & its implications for informing future therapies: pubmed.ncbi.nlm.nih.gov/38826788/. @LurieCancer

Ready for the 2024 @LurieCancer Survivors’ Celebration Walk with @stethospeaks @RChojak @atiqueahmedphd